At the end of Q3 2024, 30 institutions reported holding Phoenix Biotech Acq -CW26 (CEROW) in their 13F filings, down 4 from Q2 2024. 1 opened new positions and 4 sold out. The largest holders were Cowen and Company, LLC ($4K), Cantor Fitzgerald, L. P. ($2K) and Blue Owl Capital Holdings LP ($2K).
Company
Phoenix Biotech Acq -CW26
Filed as
CERO THERAPEUTICS HLDGS INC (Q3 2024)
CUSIP
71902K113
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
Institutions
Total Value
New Positions
1
$2K
Exits
4
$6K
All 13F filers, Q2 2024 → Q3 2024: 275,230 shares bought and 359,187 shares sold, net −83,957 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.